基于菌素的抗微生物预防的有效性,用于跨直肠超声波引导的前列腺活检:一项韩国多中心研究
Do Gyeong Lim1, Seung Il Jung2, Eu Chang Hwang1
1Department of Urology, Chonnam National University Medical School, Gwangju, Korea.
Investigative and clinical urology
|June 21, 2023
概括
结合诺基诺 (FQ) 和菌素 (FM) 抗生素,可显著减少通过直肠超声波引导前列腺活检 (TRUSPB) 后的感染性并发症. 医疗保健的使用被确定为这些活检后感染的关键风险因素.
科学领域:
- 传染性疾病 传染性疾病
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
背景情况:
- 通过直肠超声导向前列腺活检 (TRUSPB) 后感染并发症的增加与耐诺 (FQ) 生物体有关.
- 抗生素预防对于预防这些感染至关重要,但耐药性模式需要评估替代策略.
研究的目的:
- 调查基于菌素 (FM) 的抗生素预防是否可以减少 TRUSPB 后的感染.
- 确定导致TRUSPB后感染并发症的独立风险因素.
主要方法:
- 在韩国 (2018-2021) 进行的一项多中心研究包括2595名接受前列腺活检的患者.
- 患者接受了FQ单疗法 (第一组),FM单疗法 (第二组) 或FQ和FM联合预防 (第三组).
- 分析了传染性并发症率和风险因素.
主要成果:
- 总体而言,活检后感染并发症的发生率为1.27%.
- 感染性并发症的发病率为2.4% (FQ),1.9% (FM) 和0.5% (FQ+FM),组合疗法显示显著较低的发病率 (p=0.002).
- 在多变量分析中,医疗保健利用率 (aOR 4.66) 和联合预防 (aOR 0.26) 是显著的预测因素.
结论:
- 与诺基诺和福米辛的联合抗生素预防在减少TRUSPB后的传染性并发症方面表现出比单一治疗更高的疗效.
- 医疗保健的利用已成为活检后传染性并发症的独立风险因素.
相关概念视频
Acute Pyelonephritis II: Diagnostic Studies and Management
19
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
19
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
16
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
16


